Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide

Journal of Immunology

Volumn 156, Issue 5, 1996, Pages 1916-1922

  Young, M Rita I ^a,b   Wright, Mark A ^a   Matthews, John P ^b   Malik, Imrana ^b   Prechel, Margaret ^b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; INTERLEUKIN 10; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN E2; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; CONTROLLED STUDY; GRANULOCYTE; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; LEWIS CARCINOMA; LUNG CARCINOMA; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR IMMUNOLOGY;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIFFERENTIATION; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; IMMUNITY, NATURAL; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030059765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. 2. J. Immunol. 153:1674
2. Alleva, D. G., C. J Burger, and K D. Elgert. 1994. Tumor growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ. Scand. J. Immunol. 39:31.
3. O'Mahony, A. M., G. C. O'Sullivan, J. O'Connell, T. G. Cotter, and J. K Collins. 1994. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol. 151:4847
4. Aoe, T., Y. Okamoto, and T Saito. 1995. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 181:1881.
5. Sahasrabudhe, D M., and J C. Dusel. 1994. Effect of murine interferon α/β on tumor-induced suppressor function. Cancer Immunol. Immunother. 39.360.
6. Koyama, S., and K. Fukao 1994. Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumor cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma. J. Cancer Res Clin. Oncol. 120:240.
7. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin. Cancer Res. 1:95.
8. Young, M R. I., and M. A. Wright. 1992. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors, interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res. 52:6335.
9. 2-dependent and-independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J Leukocyte Biol. 53:86.
10. Maier, T., J. H. Holda, and H. N. Claman. 1989. Natural suppressor cells. Prog Clin. Biol. Res. 238:235.
11. Hayamizu, K., H. Yahata, Y. Fukuda, and K. Dohi. 1993. Induction of natural suppressor-like cells from human adult peripheral blood lymphocytes by a K562-derived factor. Transplantation 55:1403.
12. Young, M. R. I., M. A. Wright, and M. E. Young. 1991. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune suppressive bone marrow cells. Cancer Immunol. Immunother. 33:146.
13. Lang, S. H., W. R. Miller, W. Duncan, and F. K. Habib. 1994. Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer 59:235.
14. Fu, Y.-X., J.-P. Cai, Y.-H. Chin, G. A. Watson, and D. M. Lopez. 1992. Regulation of leukocyte binding to endothelial tissue by tumor-derived GM-CSF. Int J. Cancer 50:585.
15. 3 plus γ-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immmunosuppressor cells. Cancer Res. 53:6006.
16. Schmidt-Wolf, I. G , S. Dejbakhsh-Jones, N. Ginzton, P. Greenberg, and S. Strober. 1992. T-cell subsets and suppressor cells in human bone marrow. Blood 80:3242.
17. Schreiber, K L , and J. Forman 1993. Effects of bone marrow-derived natural suppressor activity on B cell responses to lipopolysaccharide Transplantation 56:700.
18. + natural suppressor cells on IL-2 and IL-4 utilization in MLR. Transplantation 58:1096.
19. Brooks-Kaiser, J. C., L. A. Bourque, and D. W. Hoskin. 1993. Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide. Immunopharmacology 25:117.
20. Moore, S. C., S. A Theus, J. B. Barnett, and L. S Soderberg. 1992. Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell. Immunol 141:398.
21. Young, M. R. I., M. E. Young, and M. A. Wright. 1990. Stimulation of immune suppressive bone marrow cells by colony stimulating factors. Exp. Hematol. 18. 806.
22. Moore, S. C., M. A. Shaw, and S. F. Soderberg. 1992. Transforming growth factor-β is the major mediator of natural suppressor cells derived from normal bone marrow. J. Leukocyte Biol. 52:596.
23. Rodriguez, R., I. Angulo, J. E. Vinuela, M. Medina, J. Gil, and J. L. Subiza. 1994. Inhibition of bone marrow-derived natural suppressor activity by glucocorticoids and its reversal by IFN-γ or IL-2 Transplantation 58:511.
24. Brooks-Kaiser, J., and D. W Hoskin. 1993. Inhibition of DNA synthesis and IL-2 bioactivity in MLR by splenic pregnancy-associated natural suppressor cells involves the production of a TGF-β1-like molecule and a second distinct inhibitory factor. J. Reprod. Immunol. 25.32.
25. Young, M R. I., M. A. Wright, M. Coogan, M E. Young, and J Bagash. 1992. Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunol Immunother. 35:14.
26. Morioka, Y , M. Naito, T. Sato, and K. Takahashi. 1994. Immunophenotypic and ultrastructural heterogeneity of macrophage differentiation in bone marrow and fetal hematopoiesis of mouse in vitro and in vivo. J. Leukocyte Biol. 55 642.
27. Wijffels, J. F. A. M., Z. de Rover, G. Kraal, and R. H. J. Beelen. 1993. Macrophage phenotype regulation by colony-stimulating factors at bone marrow level. J. Leukocyte Biol 53:249.
28. + tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte-macrophage progenitor cells with low doses of interferon-γ plus tumor necrosis factor-α. Cancer Immunol. Immunother 38:9.
29. Young, M. R , S. Aquino, and M. E. Young. 1989. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J. Leukocyte Biol. 45:262
30. 3 diminishes tumor-induced myelopoiesis and associated immune suppression, and reduces tumor metastasis and recurrence. Cancer Immunol. Immunother. 41:37.
31. Samal, B. B., G. W. Steams, T C. Boone, and T. Arakawa. 1993. Comparative analysis of the effects of recombinant cytokines on the growth and differentiation of ML-1, a human myelogenous leukemic cell line. Leuk. Res. 17.299.
32. Ferrajoli, A , M Talpaz, R Kurzrock, and Z. Estrov 1993. Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis. Stem Cells 11:112.
33. Ruhl, S., and D. H. Pluznik. 1993. Dissociation of early and late markers of murine myeloid differentiation by interferon-γ and interleukin-6. J. Cell. Physiol 155:139.
34. Geissler, K , G. Tricot, T. Leemhuis, E. Walker, and H. E. Broxmeyer. 1989. Differentiation-inducing effect of recombinant human tumor necrosis factor α and γ-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia. Cancer Res 49:3057.
35. Young, M. R. I., M. E. Young, and M. A. Wright. 1990. Myelopoiesis-associated suppressor cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int J Cancer 46:245.
36. Schmidt-Pak, A., G. Ip, M. A. Wright, and M. R. I. Young. 1995. Treating tumor-bearing mice with low dose interferon-γ plus rumor necrosis factor-α to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to IL-2 immunotherapy. Cancer Res. 55.885.
37. Hogan, M. M., and S. N. Vogel. 1991. Measurement of tumor necrosis factor α and β. In Current Protocols in Immunology. I. E. Coligan, A. M Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing Associates & Wiley-Interscience, New York, p 6.10.1.
38. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp. Med. 169:1543.
39. Tarazona, R , A. Gonzalez-Garcia, N. Zamzami, P. Marchetti, N Frechin, J. A. Gonzalo, M Ruiz-Gayo, N. van Rooijen, C Martinez, and G. Kroemer. 1995. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 154:861.
40. Walker, T. M , C. J. Burger, and K D. Elgert 1994. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cell Immunol. 154:342.
41. Alleva, D. G., T. M. Walker, and K. D. Elgert. 1995. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β1: contrasting effects on resting and activated macrophages. J. Leukocyte Biol. 57:919.
42. Angulo, I., R Rodriguez, B. Garcia, M. Medina, J. Navarro, and J. L. Subiza. 1995 Involvement of nitric oxide in bone marrow-derived natural suppressor activity, its dependence on IFN-γ. J. Immunol. 155:15.
43. Xie, Q., and C. Nathan 1994. The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol 56:576
44. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages, arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146 2719.
45. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020.
46. Kehrl, J. H , L. M. Wakefield, A. B Roberts, S. Jakowlew, M. Alvarez-Mon, M. B Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp. Med. 163:1037.
47. Shibata, Y., and A. Volkman. 1991. Restoration of prostaglandin releasing macrophage populations in lethally irradiated mice with spleen cells from bone marrow-depleted donors. J Leukucyte Biol 49:397.
48. Subiza, J L., J. E. Vinuela, R. Rodriguez, J. Gil, M. A. Figueredo, and E G De la Concha. 1989. Development of splenic natural suppressor cells in Ehrlich tumor-bearing mice. Int. J. Cancer 44:307.
49. Inamura, N., S. Sone, A. Okubo, S. M. Singh, and T. Ogura. 1990. Heterogeneity in responses of human blood monocytes to granulocyte-macrophage colony-stimulating factor. J. Leukocyte Biol 47:528.
50. Sugiura, K., S. Ikehara, M. Inaba, S. Haraguchi, H Ogata, E. E. Sardina, M. Sugawara, Y. Ohta, and R. A Good. 1992. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. Exp. Hematol. 20:256.
51. Hoskin, D. W., D. A Bowser, and J. C. Brooks-Kaiser. 1992. Soybean agglutinin-positive natural suppressor cells in mouse bone marrow inhibit interteukin 2 production and utilization in mixed lymphocyte reactions. J. Leukocyte Biol. 51:649.
52. Pavel, P., E. Halapi, E. K. Pisa, E. Gerdin, C. Hising, A. Bucht, B. Gerdin, and R. Kiessling. 1992. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies Proc. Natl. Acad. Sci. USA 89:7708.
53. Nathan, C. 1992 Nitric oxide as a secretory product of mammalian cells FASEB J 6:3051.
54. Mills, C D , J Shearer, R Evans, and M. D. Caldwell. 1992. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol 149: 2709.
55. Flaumenhaft, R., S. Kojima, M Abe, and D. B. Rifkin 1993. Activation of latent transforming growth factor β. Adv. Pharmacol 24:51.
56. Vodovotz, Y., and C. Bogdan. 1994. Control of nitric oxide synthase expression by transforming growth factor-β: implications for homeostasis. Prog Growth Factor Res 5:341.
57. Nikcevich, D. A., M. R. Young, N. K. Ellis, M. Newby, and H. T. Wepsic 1986 Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis. J Immunopharmacol. 8.299.
58. Pelus, L M. 1989. Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units: granulocyte, macrophage) after acute administration of recombinant human IL-1α. J. Immunol. 143:4171.